Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis

References

• BourneRRStevensGAWhiteRACauses of vision loss worldwide, 1990–2010: a systematic analysisLancet Glob Health201316339349
   PubMed Web of Science ®Google Scholar
• ThamYCLiXWongTYQuigleyHAAungTChengCYGlobal prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysisOphthalmology2014121112081209024974815
   PubMed Web of Science ®Google Scholar
• AritaRItohKMaedaSComparison of the long-term effects of various topical antiglaucoma medications on meibomian glandsCornea201231111229123422406943
   PubMed Web of Science ®Google Scholar
• FechtnerRDGodfreyDGBudenzDStewartJAStewartWCJasekMCPrevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medicationsCornea201029661862120386433
   PubMed Web of Science ®Google Scholar
• GhoshSO’HareFLamoureuxEVajpayeeRBCrowstonJGPrevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medicationClin Experiment Ophthalmol201240767568122394358
   PubMed Web of Science ®Google Scholar
• LeungEWMedeirosFAWeinrebRNPrevalence of ocular surface disease in glaucoma patientsJ Glaucoma200817535035518703943
   PubMed Web of Science ®Google Scholar
• Garcia-FeijooJSampaolesiJRA multicenter evaluation of ocular surface disease prevalence in patients with glaucomaClin Ophthalmol2012644144622536034
   PubMedGoogle Scholar
• AnwarZWellikSRGalorAGlaucoma therapy and ocular surface disease: current literature and recommendationsCurr Opin Ophthalmol201324213614323542350
   PubMed Web of Science ®Google Scholar
• StewartWCStewartJANelsonLAOcular surface disease in patients with ocular hypertension and glaucomaCurr Eye Res201136539139821501071
   PubMed Web of Science ®Google Scholar
• HerrerasJMPastorJCCalongeMAsensioVMOcular surface alteration after long-term treatment with an anti-glaucomatous drugOphthalmology1992997108210881495787
   PubMed Web of Science ®Google Scholar
• AriciMKAriciDSTopalkaraAGulerCAdverse effects of topical anti-glaucoma drugs on the ocular surfaceClin Experiment Ophthalmol20002811311710933774
   PubMed Web of Science ®Google Scholar
• AiharaMOtaniSKozakiJLong-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprostJ Glaucoma2012211606421278589
   PubMed Web of Science ®Google Scholar
• ThygesenJAaenKTheodorsenFKessingSVPrauseJUShort-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertensionActa Ophthalmol Scand2000781374110726786
   PubMedGoogle Scholar
• WatsonPStjernschantzJA six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study GroupOphthalmology199610311261378628543
   PubMed Web of Science ®Google Scholar
• CamrasCBComparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study GroupOphthalmology199610311381478628544
   PubMed Web of Science ®Google Scholar
• KuppensEVStolwijkTRde KeizerRJvan BestJABasal tear turnover and topical timolol in glaucoma patients and healthy controls by fluorophotometryInvest Ophthalmol Vis Sci19923312344234481428718
   PubMed Web of Science ®Google Scholar
• Van BuskirkEMCorneal anesthesia after timolol maleate therapyAm J Ophthalmol1979884739743507147
   PubMed Web of Science ®Google Scholar
• Van BuskirkEMAdverse reactions from timolol administrationOphthalmology19808754474507402590
   PubMed Web of Science ®Google Scholar
• WilsonRPSpaethGLPoryzeesEThe place of timolol in the practice of ophthalmologyOphthalmology19808754514547402591
   PubMed Web of Science ®Google Scholar
• AlmAStjernschantzJEffects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study GroupOphthalmology199510212174317529098273
   PubMed Web of Science ®Google Scholar
• SherwoodMBGriersonIMillarLHitchingsRALong-term morphologic effects of anti-glaucoma drugs on the conjunctiva and Tenon’s capsule in glaucoma patientsOphthalmology19899633273352710524
   PubMed Web of Science ®Google Scholar
• BrandtJDWittpennJRKatzLJSteinmannWNSpaethGLConjunctival impression cytology in patients with glaucoma using long-term topical medicationAm J Ophthalmol199111232973011679298
   PubMed Web of Science ®Google Scholar
• BaudouinCGarcherCHaouatNBronAGastaudPExpression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucomaOphthalmology199410134544607907416
   PubMed Web of Science ®Google Scholar
• BaudouinCLiangHHamardPThe ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathwaysOphthalmology2008115110911517532048
   PubMed Web of Science ®Google Scholar
• MirzaSKHigginbothamEJIatrogenic glaucoma therapy failure: the adverse effects of topical glaucoma medication treatment outcomeExpert Rev Clin Pharmacol200921879924422774
   PubMedGoogle Scholar
• LeeSYWongTTChuaJBooCSohYFTongLEffect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarityEye (Lond)201327101142115023846375
   PubMed Web of Science ®Google Scholar
• Neves MendesCRHidaRYKasaharaNOcular surface changes in eyes with glaucoma filtering blebsCurr Eye Res201237430931122440162
   PubMed Web of Science ®Google Scholar
• LamJWongTTTongLOcular surface disease in posttrabeculectomy/mitomycin C patientsClin Ophthalmol2015918719125678766
   PubMedGoogle Scholar
• The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Work Shop (2007)Ocul Surf200752759217508116
   PubMed Web of Science ®Google Scholar
• Fuentes-PaezGHerrerasJMCorderoYAlmarazAGonzalezMJCalongeMLack of concordance between dry eye syndrome questionnaires and diagnostic testsArch Soc Esp Oftalmol201186137 Spanish21414523
   PubMedGoogle Scholar
• MooreJEGrahamJEGoodallEAConcordance between common dry eye diagnostic testsBr J Ophthalmol2009931667218782801
   PubMed Web of Science ®Google Scholar
• ChalmersRLBegleyCGEdringtonTThe agreement between self-assessment and clinician assessment of dry eye severityCornea200524780481016160496
   PubMed Web of Science ®Google Scholar
• VersuraPCelliniMTorreggianiAProfazioVBernabiniBCaramazzaRDryness symptoms, diagnostic protocol and therapeutic management: a report on 1,200 patientsOphthalmic Res200133422122711464075
   PubMed Web of Science ®Google Scholar
• MaletFLe GoffMColinJDry eye disease in French elderly subjects: the Alienor studyActa Ophthalmol2014926e429e43623742664
   PubMed Web of Science ®Google Scholar
• SaadeCELariHBBerezinaTLFechtnerRDKhouriASTopical glaucoma therapy and ocular surface disease: a prospective controlled cohort studyCan J Ophthalmol201550213213625863853
   PubMed Web of Science ®Google Scholar
• OnoTYukiKOzekiNShibaDTsubotaKOcular surface complications after trabeculectomy: incidence, risk factors, time course and prognosisOphthalmologica20132302939923774034
   PubMed Web of Science ®Google Scholar
• SchwartzGSHollandEJIatrogenic limbal stem cell deficiency: when glaucoma management contributes to corneal diseaseJ Glaucoma200110644344511740212
   PubMed Web of Science ®Google Scholar
• RolandoMZierhutMThe ocular surface and tear film and their dysfunction in dry eye diseaseSurv Ophthalmol200145Suppl 2S203S21011587144
   PubMed Web of Science ®Google Scholar
• VarmaRLeePPGoldbergIKotakSAn assessment of the health and economic burdens of glaucomaAm J Ophthalmol2011152451552221961848
   PubMed Web of Science ®Google Scholar
• ReinDBZhangPWirthKEThe economic impact of major visual disorders in the United StatesArch Ophthalmol2006124121754176017159036
   PubMedGoogle Scholar